2m 2m 2m 2m 2m 2m 2m
Insulet (PODD)
NASDAQ
$132.50+$0.54 (+0.41%)
Price as of Sep 11, 2026 7:30 PM EDT- $9.2BMarket Cap
- -61.39%1-Year Change
- Medical DevicesIndustry
Insulet (PODD)
$132.50+$0.54 (+0.41%)
PODD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $131.96 | ||
Change | -$2.72 (-2.02%) | ||
Open | $135.40 | ||
High | $135.57 | ||
Low | $131.24 | ||
Previous Close | $134.68 | ||
Volume | 1,747,977 | ||
30-Day Average Volume | 1,690,871 | ||
1-Week Change | -10.52% | ||
1-Month Change | -8.80% | ||
1-Year Change | -61.39% | ||
3-Year Change | -24.71% | ||
5-Year Change | -55.48% | ||
Fundamentals | |||
Shares Outstanding | 69.4M | ||
Total Assets | $3.2B | ||
Market Cap | $9.2B | ||
Enterprise Value | $10.0B | ||
Period: QTR TTM FY | |||
Revenue | $801.7M | ||
Net Income | $95.0M | ||
Free Cash Flow | $55.9M | ||
EBIT | $118.7M | ||
EBITDA | $145.4M | ||
Net Working Capital | $1.1B | ||
EPS | $1.37 | ||
Enterprise Value/EBITDA | 69 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 6 | ||
P/E | 96 | ||
PEG | 18 | ||
Price/Free Cash Flow | 164 | ||
Price/Operating Cash Flow | 104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue